On Friday, January 4th, The Yield Growth Corp. (CSE:BOSS) announced its intention to apply for a micro-processing license, a research license and a medical sales license under the Cannabis Act in Canada.
According to the release, “Yield Growth plans to apply for these licenses so it will legally be able to infuse its full line of wellness products with Cannabinoids, including in particular CBD and THC, and sell them in Canada.”
Health Canada has already proposed regulations for cannabis edibles, extracts, and topicals which are expected to be adopted into law in October 2019. If all goes as planned, Yield Growth intends to be a leader in this new industry.
To help BOSS secure the licenses, the company has engaged Incanco Cannabis Consultants, which has also worked with MYM Nutraceuticals Inc. (CSE:MYM) (OTC:MYMMF), Valens GroWorks Corp. (CSE:VGW) (OTC:MYMSF) and more. Incanco Cannabis Consultants has also been engaged to assist in finding international opportunities for Yield Growth and to assist in developing a plan to launch a hemp root oil extraction and production facility.
As payment, Yield Growth issued Incanco Cannabis 200,000 units, each unit consisting of one share and one warrant to purchase another share at $0.34 CAD. The agreement is a five-year term, and additional compensation is payable to Incanco throughout the term.
Incanco’s principal, John W. Conroy, Q.C., is one of Canada’s leading experts on cannabis law with over 40 years’ experience in the area, so as he begins assisting Yield Growth with their Health Canada license applications, we’ll be sure to keep an eye out for updates.
In the meantime, be sure to subscribe to updates here so you never miss an important update.
Get Real-Time Updates from MJobserver.com